Fred Dom

Fred Dom is a serial entrepreneur with expertise in private capital investment, setting up and leading biotech companies. Today he is managing director and co-founder of HiFiBiO SAS, a clinical stage biotech company that raised over $ 200 million to advance a pipeline of therapeutic antibodies making use of the power of droplet based microfluidics. Fred also co-founded BioMillenia (Paris) that merged with Design Pharmaceuticals and holds board positions in Calyxia and Kapsera (micro encapsulation companies based in France). Fred is a member of the Dutch Advisory Board of life science and health” and AcTi (Academy of Technology and Innovation). Fred holds a B.Sc. and M.Sc. from Erasmus University in Rotterdam, the Netherlands.